Evidence map›Paper›PMID 41694993›Full record

ArticleCureus2026

When the Eyes Go Dark: Transient Cortical Blindness After Primary Percutaneous Coronary Intervention.

Soufiane Touiti, Oumayma El Khabote, Siham Hallab, Nada Fennich, Latifa Oukerraj, Mohamed Cherti

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Soufiane TouitiDepartment of Clinical Cardiology, Cardiology B Hospital, Mohammed V University of Rabat, Rabat, MAR.
Oumayma El KhaboteDepartment of Cardiac Catheterization, Cardiology B Hospital, Mohammed V University of Rabat, Rabat, MAR.
Siham HallabDepartment of Clinical Cardiology, Cardiology B Hospital, Mohammed V University of Rabat, Rabat, MAR.
Nada FennichDepartment of Cardiac Catheterization, Cardiology B Hospital, Mohammed V University of Rabat, Rabat, MAR.
Latifa OukerrajDepartment of Cardiac Catheterization, Cardiology B Hospital, Mohammed V University of Rabat, Rabat, MAR.
Mohamed ChertiDepartment of Clinical Cardiology, Cardiology B Hospital, Mohammed V University of Rabat, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient cortical blindness is a rare neurological complication associated with iodinated contrast media used during coronary angiography and percutaneous coronary intervention (PCI). Although uncommon, its sudden onset may mimic acute stroke, creating diagnostic uncertainty and significant anxiety. We report the case of a 49-year-old woman with a three-year history of type 2 diabetes mellitus who presented with prolonged retrosternal chest pain. ECG revealed ST-segment elevation in the inferior leads, consistent with inferoposterior ST-elevation myocardial infarction. Coronary angiography demonstrated an occlusion of the proximal right coronary artery, and successful primary PCI was performed with restoration of thrombolysis in myocardial infarction 3 flow. Near the end of the procedure, the patient developed acute bilateral blindness, preceded by visual fog, despite stable vital signs and the absence of focal neurological deficits. An urgent brain CT and subsequent MRI with angiographic sequences, performed four hours after symptom onset, were unremarkable. Supportive management with intravenous hydration was initiated, and the patient experienced complete visual recovery within 24 hours. The clinical presentation, normal neuroimaging, and rapid resolution were consistent with contrast-induced cortical blindness, a phenomenon attributed to transient blood-brain barrier disruption and direct neurotoxic effects of contrast agents on the occipital cortex. Although self-limited, recognizing this rare complication is crucial to distinguish it from ischemic stroke or posterior reversible encephalopathy syndrome and to prevent unnecessary interventions. Contrast-induced cortical blindness remains a reversible but impactful complication of PCI, and early recognition, exclusion of alternative diagnoses, supportive care, and patient reassurance are essential for optimal management.

Indexed as

contrast-induced neurotoxicitycortical blindnessdiabetes mellitusprimary percutaneous coronary interventionst-elevation myocardial infarction

Identifiers

PMID41694993
PMCPMC12903049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.